相关实验视频
Updated: Jun 14, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.7K
黑色素瘤的新辅助疗法:过去,现在和未来
Aaron D Therien1, Chinecherem M Chime-Eze2, Kristen E Rhodin3
1Duke University School of Medicine, Durham, NC, USA.
Surgical oncology
|September 5, 2024
概括
在手术前使用免疫疗法和向治疗的新辅助疗法,现在是晚期黑色素瘤的标准. 研究继续优化治疗选择和手术方法,以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 手术瘤学手术瘤学
背景情况:
- 系统疗法显著改善了晚期转移性黑色素瘤的治疗结果.
- 辅助免疫疗法和向疗法已被批准用于切除的III期黑色素瘤.
- 新辅助疗法越来越多地用于黑色素瘤早期阶段.
研究的目的:
- 为提供对黑色素瘤新辅助疗法的概述.
- 讨论当前的困境和新辅助疗法应用的未来方向.
主要方法:
- 随机对照试验的综述,确定新辅助疗法作为标准护理.
- 对当前临床实践和新辅助性黑色素瘤治疗的持续研究进行分析.
主要成果:
- 根据有希望的试验结果,新辅助疗法已成为高级黑色素瘤患者的标准护理.
- 对适应这些疗法用于早期疾病阶段存在重大科学兴趣.
结论:
- 虽然新辅助疗法已经确立,但最佳治疗选择,持续时间,时间,手术程度以及辅助疗法的作用需要进一步调查.
- 解决这些困境对于扩大新辅助疗法在黑色素瘤管理中的应用至关重要.
相关概念视频
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K

